Latest Period
Q1 2026
Security Snapshot
Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) Institutional Ownership
CUSIP: 753018100
13F Institutional Holders and Ownership History from Q3 2021 to Q1 2026
Institutions Reporting
72
Shares (Excl. Options)
42,720,067
Price
$0.73
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Stock, $0.0001 par value per share
- Symbol
- RANI on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 42,720,067
- Total 13F value
- $31,392,943
- Portfolio coverage rank
- 0%
- Share change
- -2,092,107
- Value change
- -$1,642,213
- Number of holders
- 72
- Shares outstanding
- 114,373,343
- SEC-reported price per share
- $1.10
- Insider filing price
- $1.10
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share is tracked under CUSIP 753018100.
- 72 institutions reported positions in Q1 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 61 to 72 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $60,478,537 to $31,392,943.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 72 institutions filings for Q1 2026.
Security key
753018100
Latest holder period
Q1 2026
13F holders
72
13D/G owners
9
CIK / CUSIP context first
Open Q1 2026 holders
RANI full holder history
Rani Therapeutics Holdings, Inc. SEC filings
Rani Therapeutics Holdings, Inc. company facts
Rani Therapeutics Holdings, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 753018100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
RANI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| InCube Labs, L.L.C. | 22% | $13,541,357 | 27,093,552 | MIR A IMRAN | 23 Oct 2025 | |||
| Samsara BioCapital, L.P. | 9.9% | 0% | $10,417,124 | +$1,325,245 | 11,322,961 | +15% | Srinivas Akkaraju | 26 May 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | $4,939,262 | 9,882,477 | RA Capital Management, L.P. | 23 Oct 2025 | |||
| Invus Global Management, LLC | 10% | $4,910,990 | 9,825,911 | Raymond Debbane | 16 Oct 2025 | |||
| AWM Investment Company, Inc. | 9.9% | $14,520,561 | 9,745,343 | AWM Investment Company, Inc. | 31 Dec 2025 | |||
| ARMISTICE CAPITAL, LLC | 9.9% | $4,131,600 | 6,260,000 | Armistice Capital, LLC | 30 Jun 2025 | |||
| VANGUARD GROUP INC | 5.2% | $6,897,647 | 5,109,368 | The Vanguard Group | 31 Dec 2025 | |||
| South Cone Investments Limited Partnership | 4.9% | $1,189,121 | 2,379,194 | South Cone Investments Limited Partnership | 20 Oct 2025 | |||
| Orca Capital AG | 4.3% | -56% | $972,105 | -$1,265,416 | 1,891,623 | -57% | Orca Capital AG | 22 Jul 2025 |
As of 31 Mar 2026, 72 institutional investors reported holding 42,720,067 shares of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI). This represents 37% of the company’s total 114,373,343 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
36%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7.4% | 8,500,000 | 0% | 0.07% | $6,245,800 |
| SAMSARA BIOCAPITAL, LLC | 7.4% | 8,500,000 | 0% | 0.61% | $6,245,800 |
| AWM Investment Company, Inc. | 5.7% | 6,500,000 | 0% | 0.53% | $4,776,200 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 4,622,567 | 0% | 0% | $3,397,587 |
| SymBiosis Capital Partners, LLC | 3.2% | 3,667,585 | -42% | 5.1% | $2,694,941 |
| Longaeva Partners L.P. | 2% | 2,329,459 | +10% | 0.08% | $1,711,686 |
| Siren, L.L.C. | 1.7% | 2,000,000 | 0% | 0.04% | $1,469,600 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.79% | 903,298 | +4.9% | 0% | $664,060 |
| BlackRock, Inc. | 0.49% | 556,889 | +5.5% | 0% | $409,202 |
| Nan Fung Group Holdings Ltd | 0.43% | 493,584 | 0% | 0.3% | $362,686 |
| 683 Capital Management, LLC | 0.43% | 487,168 | 0% | 0.03% | $357,971 |
| VANGUARD FIDUCIARY TRUST CO | 0.4% | 455,050 | 0% | 0% | $334,462 |
| MILLENNIUM MANAGEMENT LLC | 0.35% | 405,669 | +148% | 0% | $298,086 |
| STATE STREET CORP | 0.33% | 373,142 | -3.6% | 0% | $274,185 |
| UNITED SERVICES AUTOMOBILE ASSOCIATION | 0.26% | 302,743 | 0% | 0.03% | $222,456 |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 0.23% | 265,159 | +4.1% | 0% | $194,839 |
| UBS Group AG | 0.2% | 227,223 | +50% | 0% | $167,009 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.16% | 188,222 | +231% | 0% | $138,306 |
| NORTHERN TRUST CORP | 0.15% | 170,471 | 0% | 0% | $125,262 |
| JANE STREET GROUP, LLC | 0.14% | 165,599 | 0% | $121,682 | |
| Hudson Bay Capital Management LP | 0.13% | 153,331 | 0% | $112,668 | |
| CWA Asset Management Group, LLC | 0.13% | 150,000 | 0% | 0% | $110,220 |
| Cygnus Capital Advisors, LLC | 0.1% | 115,649 | 0.06% | $85,000 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.1% | 114,500 | 0% | 0% | $84,135 |
| GSA CAPITAL PARTNERS LLP | 0.08% | 96,998 | 0% | $71,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
19
Latest
Q1 2026
Rows shown
1-19 of 19
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 42,720,067 | $31,392,943 | -$1,642,213 | $0.73 | 72 |
| 2025 Q4 | 44,799,019 | $60,478,537 | +$47,505,485 | $1.35 | 61 |
| 2025 Q3 | 4,033,213 | $2,015,817 | -$1,258,453 | $0.50 | 36 |
| 2025 Q2 | 6,458,632 | $3,319,783 | +$1,060,111 | $0.51 | 38 |
| 2025 Q1 | 3,609,389 | $4,577,211 | -$332,797 | $1.26 | 38 |
| 2024 Q4 | 3,819,967 | $5,233,595 | -$4,950,047 | $1.37 | 42 |
| 2024 Q3 | 5,911,071 | $12,767,865 | +$5,999,502 | $2.16 | 31 |
| 2024 Q2 | 3,108,475 | $11,809,884 | -$1,252,441 | $3.80 | 33 |
| 2024 Q1 | 3,453,784 | $10,741,251 | +$509,498 | $3.11 | 35 |
| 2023 Q4 | 3,290,303 | $10,923,496 | -$819,783 | $3.32 | 33 |
| 2023 Q3 | 3,207,291 | $6,961,738 | -$151,646 | $2.18 | 32 |
| 2023 Q2 | 3,227,286 | $13,256,941 | +$994,179 | $4.12 | 34 |
| 2023 Q1 | 2,999,366 | $15,475,095 | +$204,634 | $5.16 | 35 |
| 2022 Q4 | 2,885,407 | $17,024,416 | -$1,472,942 | $5.90 | 32 |
| 2022 Q3 | 3,174,344 | $30,405,447 | +$3,581,808 | $9.58 | 30 |
| 2022 Q2 | 2,824,819 | $29,094,000 | +$2,769,956 | $10.33 | 27 |
| 2022 Q1 | 2,556,816 | $34,515,000 | +$17,568,047 | $13.50 | 23 |
| 2021 Q4 | 1,240,919 | $20,288,000 | +$544,189 | $16.35 | 21 |
| 2021 Q3 | 1,097,698 | $19,562,000 | +$19,562,000 | $17.82 | 14 |